$1.67
In chiusura: Nov 11 EDT
$1.69
0.021.20%
Pre-mercato: 4:13 AM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Akebia Therapeutics Inc (NASDAQ:AKBA) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 29.40M a 29.32M. Questo rappresenta il 11.17% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 2.69M azioni scambiate al giorno, ci vorrebbero 10.91 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
29.32M
Vendite allo scoperto %
11.2%
Giorni di copertura
10.91
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
AKBA | Akebia Therapeutics, Inc. Comm | 10/15/2025 | 10/24/2025 | 11.17% | 262,420,462 | 29,319,644 | 2,687,857 | 10.91 | |
AKBA | Akebia Therapeutics, Inc. Comm | 09/30/2025 | 10/09/2025 | 11.20% | 262,420,462 | 29,401,452 | 3,190,649 | 9.21 | |
AKBA | Akebia Therapeutics, Inc. Comm | 09/15/2025 | 09/24/2025 | 10.43% | 262,420,462 | 27,363,386 | 3,859,359 | 7.09 | |
AKBA | Akebia Therapeutics, Inc. Comm | 08/29/2025 | 09/10/2025 | 10.32% | 262,420,462 | 27,090,731 | 3,833,176 | 7.07 | |
AKBA | Akebia Therapeutics, Inc. Comm | 08/15/2025 | 08/26/2025 | 9.46% | 262,420,462 | 24,814,352 | 4,502,272 | 5.51 | |
AKBA | Akebia Therapeutics, Inc. Comm | 07/31/2025 | 08/11/2025 | 9.35% | 262,420,462 | 24,538,006 | 3,063,807 | 8.01 | |
AKBA | Akebia Therapeutics, Inc. Comm | 07/15/2025 | 07/24/2025 | 9.76% | 259,911,260 | 25,373,233 | 3,453,699 | 7.35 | |
AKBA | Akebia Therapeutics, Inc. Comm | 06/30/2025 | 07/10/2025 | 9.81% | 259,911,260 | 25,504,822 | 4,908,029 | 5.2 | |
AKBA | Akebia Therapeutics, Inc. Comm | 06/13/2025 | 06/25/2025 | 7.12% | 259,911,260 | 18,498,837 | 7,824,186 | 2.36 | |
AKBA | Akebia Therapeutics, Inc. Comm | 05/30/2025 | 06/10/2025 | 7.72% | 259,911,260 | 20,053,575 | 5,137,665 | 3.9 | |
AKBA | Akebia Therapeutics, Inc. Comm | 05/15/2025 | 05/27/2025 | 7.59% | 259,911,260 | 19,722,763 | 4,497,731 | 4.39 | |
AKBA | Akebia Therapeutics, Inc. Comm | 04/30/2025 | 05/09/2025 | 6.86% | 258,983,830 | 17,770,222 | 2,888,147 | 6.15 | |
AKBA | Akebia Therapeutics, Inc. Comm | 04/15/2025 | 04/25/2025 | 6.92% | 258,983,830 | 17,922,367 | 5,010,261 | 3.58 | |
AKBA | Akebia Therapeutics, Inc. Comm | 03/31/2025 | 04/09/2025 | 6.70% | 258,983,830 | 17,357,699 | 7,127,696 | 2.44 | |
AKBA | Akebia Therapeutics, Inc. Comm | 03/14/2025 | 03/25/2025 | 6.40% | 258,983,830 | 16,570,902 | 4,228,947 | 3.92 | |
AKBA | Akebia Therapeutics, Inc. Comm | 02/28/2025 | 03/11/2025 | 6.89% | 215,933,975 | 14,879,018 | 2,396,279 | 6.21 | |
AKBA | Akebia Therapeutics, Inc. Comm | 02/14/2025 | 02/26/2025 | 6.94% | 215,933,975 | 14,981,253 | 1,612,570 | 9.29 | |
AKBA | Akebia Therapeutics, Inc. Comm | 01/31/2025 | 02/11/2025 | 6.69% | 215,933,975 | 14,453,171 | 2,698,999 | 5.36 | |
AKBA | Akebia Therapeutics, Inc. Comm | 01/15/2025 | 01/27/2025 | 8.33% | 215,933,975 | 17,994,029 | 2,155,107 | 8.35 | |
AKBA | Akebia Therapeutics, Inc. Comm | 12/31/2024 | 01/10/2025 | 7.72% | 215,933,975 | 16,678,310 | 2,085,518 | 8 | |
AKBA | Akebia Therapeutics, Inc. Comm | 12/13/2024 | 12/24/2024 | 6.52% | 215,933,975 | 14,069,487 | 2,099,412 | 6.7 | |
AKBA | Akebia Therapeutics, Inc. Comm | 11/29/2024 | 12/10/2024 | 5.35% | 215,933,975 | 11,557,619 | 1,909,781 | 6.05 | |
AKBA | Akebia Therapeutics, Inc. Comm | 11/15/2024 | 11/26/2024 | 5.54% | 215,933,975 | 11,961,601 | 2,841,464 | 4.21 | |
AKBA | Akebia Therapeutics, Inc. Comm | 10/31/2024 | 11/11/2024 | 7.13% | 208,040,983 | 14,835,319 | 2,148,384 | 6.91 | |
AKBA | Akebia Therapeutics, Inc. Comm | 10/15/2024 | 10/24/2024 | 8.50% | 208,040,983 | 17,684,317 | 1,096,890 | 16.12 | |
AKBA | Akebia Therapeutics, Inc. Comm | 09/30/2024 | 10/09/2024 | 9.04% | 208,040,983 | 18,803,189 | 1,369,087 | 13.73 | |
AKBA | Akebia Therapeutics, Inc. Comm | 09/13/2024 | 09/24/2024 | 9.16% | 208,040,983 | 19,061,334 | 1,528,209 | 12.47 | |
AKBA | Akebia Therapeutics, Inc. Comm | 08/30/2024 | 09/11/2024 | 9.17% | 208,040,983 | 19,067,933 | 1,668,125 | 11.43 | |
AKBA | Akebia Therapeutics, Inc. Comm | 08/15/2024 | 08/26/2024 | 9.11% | 208,040,983 | 18,945,342 | 2,097,612 | 9.03 | |
AKBA | Akebia Therapeutics, Inc. Comm | 07/31/2024 | 08/09/2024 | 8.63% | 207,349,151 | 17,889,086 | 2,186,803 | 8.18 | |
AKBA | Akebia Therapeutics, Inc. Comm | 07/15/2024 | 07/24/2024 | 9.00% | 207,349,151 | 18,663,113 | 3,050,181 | 6.12 | |
AKBA | Akebia Therapeutics, Inc. Comm | 06/28/2024 | 07/10/2024 | 6.32% | 207,349,151 | 13,114,139 | 6,524,633 | 2.01 | |
AKBA | Akebia Therapeutics, Inc. Comm | 06/14/2024 | 06/26/2024 | 5.93% | 207,349,151 | 12,296,514 | 1,870,195 | 6.57 | |
AKBA | Akebia Therapeutics, Inc. Comm | 05/31/2024 | 06/11/2024 | 6.34% | 207,349,151 | 13,155,199 | 2,461,652 | 5.34 | |
AKBA | Akebia Therapeutics, Inc. Comm | 05/15/2024 | 05/24/2024 | 5.64% | 207,349,151 | 11,698,707 | 3,302,665 | 3.54 | |
AKBA | Akebia Therapeutics, Inc. Comm | 04/30/2024 | 05/09/2024 | 5.72% | 207,349,151 | 11,864,826 | 2,690,609 | 4.41 | |
AKBA | Akebia Therapeutics, Inc. Comm | 04/15/2024 | 04/24/2024 | 6.60% | 207,348,027 | 13,689,136 | 5,798,042 | 2.36 | |
AKBA | Akebia Therapeutics, Inc. Comm | 03/28/2024 | 04/09/2024 | 6.47% | 207,157,771 | 13,400,139 | 13,542,889 | 1 | |
AKBA | Akebia Therapeutics, Inc. Comm | 03/15/2024 | 03/26/2024 | 4.89% | 207,157,771 | 10,126,415 | 3,788,922 | 2.67 | |
AKBA | Akebia Therapeutics, Inc. Comm | 02/29/2024 | 03/11/2024 | 4.22% | 192,368,035 | 8,110,931 | 2,552,839 | 3.18 | |
AKBA | Akebia Therapeutics, Inc. Comm | 02/15/2024 | 02/27/2024 | 4.30% | 186,174,911 | 8,004,939 | 1,662,120 | 4.82 | |
AKBA | Akebia Therapeutics, Inc. Comm | 01/31/2024 | 02/09/2024 | 4.72% | 186,174,911 | 8,778,246 | 2,262,643 | 3.88 | |
AKBA | Akebia Therapeutics, Inc. Comm | 01/12/2024 | 01/24/2024 | 4.21% | 186,174,911 | 7,832,705 | 2,183,063 | 3.59 | |
AKBA | Akebia Therapeutics, Inc. Comm | 12/29/2023 | 01/10/2024 | 4.23% | 186,174,911 | 7,872,876 | 1,678,085 | 4.69 | |
AKBA | Akebia Therapeutics, Inc. Comm | 12/15/2023 | 12/27/2023 | 3.94% | 186,174,911 | 7,328,941 | 1,116,557 | 6.56 | |
AKBA | Akebia Therapeutics, Inc. Comm | 11/30/2023 | 12/11/2023 | 4.84% | 186,174,911 | 9,010,651 | 705,507 | 12.77 | |
AKBA | Akebia Therapeutics, Inc. Comm | 11/15/2023 | 11/27/2023 | 5.31% | 186,174,911 | 9,881,875 | 1,780,025 | 5.55 |
In cerca di azioni più vendute allo scoperto?